Stephen Industries Inc Oy Buys Bioretec Oy Shares via Subscription (Manager’s Transactions)
April 24, 2026
Bioretec Oy disclosed managers’ transaction activity indicating that Stephen Industries Inc Oy, a closely associated party of board member Kustaa Poutiainen, subscribed for shares outside a trading venue. The transaction details were reported with an aggregated share volume and very low nominal prices per unit.
- Buyers
- Stephen Industries Inc Oy
- Targets
- Bioretec Oy
- Industry
- Medical Devices
- Location
- Finland
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
1317234 B.C. Ltd. reverse takeover of RTRS Technologies Inc., raising at least $6.85M
September 11, 2026
Medical Devices
1317234 B.C. Ltd. (“234 B.C.”) and RTRS Technologies Inc. (“RTRS”) entered into a definitive merger agreement to execute a reverse takeover that will list the combined business on the TSX Venture Exchange. Concurrently, the transaction includes a best-efforts private placement raising gross proceeds of not less than $6.85 million via subscription receipts, with Haywood Securities acting as lead agent and sole bookrunner.
-
Merck KGaA to Acquire Bio-Techne for $11.3 Billion
June 25, 2026
Healthcare Services
Merck KGaA has entered a definitive agreement to acquire Bio-Techne for $73 per share in an all-cash transaction valued at about $11.3 billion (enterprise value). The deal is expected to close in late 2026 or early 2027, subject to regulatory approvals and Bio-Techne shareholder approval.
-
Pharmaron Acquires 82.54% of Biortus Biosciences
October 28, 2025
Healthcare Services
Pharmaron Beijing Co., Limited has entered into a definitive Share Purchase Agreement to acquire 82.54% of Biortus Biosciences Co., Ltd. and its affiliates. The transaction is expected to close after satisfaction of customary closing conditions and is intended to strengthen Pharmaron’s structure-based drug discovery and protein science capabilities.
-
Biocomposites Takes Minority Stake in Renovos Biologics
July 5, 2023
Biotechnology
Biocomposites has taken a minority equity stake in Renovos Biologics to support development and pre-market approval of the RENOVITE nanoclay therapeutic delivery platform. The investment will give Renovos access to Biocomposites' development expertise and global distribution network; Biocomposites CEO Michael Harris will join Renovos' board.
-
Bridges Fund Management Acquires Majority Stake in Storetec
November 9, 2022
Professional Services
Bridges Fund Management has acquired a majority stake in Storetec, a Hull-based document digitisation, archive storage and cloud document management provider. The investment from Bridges' Sustainable Growth Funds will support Storetec's product and service expansion, strengthen its impact and ESG practices, and accelerate growth across the U.K. and into new markets.
-
Iptor Acquires TimberTec
February 1, 2022
Software
Stockholm-based Iptor acquired German TimberTec, a provider of ERP and MES software for the timber industry, in a deal that closed in February 2022. The acquisition is an add-on in Iptor's buy-and-build strategy (backed by funds advised by Bregal Unternehmerkapital) and aims to expand Iptor’s sector capabilities and geographic reach across Europe and into the US.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.